Share Name Share Symbol Market Type Share ISIN Share Description
Fitbug LSE:FITB London Ordinary Share GB00B57JBH88 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 0.1675p 0.00p 0.00p - - - 0 06:37:22
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Leisure Goods 1.3 -6.5 -2.5 - 2.90

Fitbug (FITB) Latest News

Fitbug News

Date Time Source Headline
20/6/201707:00RNSNONKin Group PLC Non Regulatory - new contract - NHS Trust
More Fitbug News
Fitbug Takeover Rumours

Fitbug (FITB) Share Charts

1 Year Fitbug Chart

1 Year Fitbug Chart

1 Month Fitbug Chart

1 Month Fitbug Chart

Intraday Fitbug Chart

Intraday Fitbug Chart

Fitbug (FITB) Discussions and Chat

Fitbug (FITB) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Fitbug trades in real-time

Fitbug (FITB) Top Chat Posts

DateSubject
08/3/2017
09:13
mudbath: The supposed 0.01pence markdown in the FITB share price this morning only brings the quote more in line with the actual prices offered over recent days. The MMs though continue to seek large parcels of stock and are currently bidding 0.134 in 10 million.. I would therefore not be surprised if the share price were marked up quite significantly before too long,even though everything might presently look pretty bleak to the casual observer.
06/2/2017
15:15
mudbath: I remain of the opinion that volatility in the FITB share price is finished,at least for a while. As before the most recent spike,any remaining interest will tend to evaporate causing the share price to perhaps edge downwards into the 0.12/0.15 region. At those lower levels it should prove rewarding to keep a close eye on the "bid" in the hope that any sudden MM interest in the stock might once again preface the next spike. Watch out for the concert party,for they have not gone away. All imo.
25/1/2017
12:01
mudbath: From the date of the 0.25 fundraising through to the flurry of RNSs' , six months elapsed. During that six months all volatility in the FITB share price evaporated(barring one small temporary blip) whilst the share price was managed downwards by some 40%.In this timeframe it was possible to buy FITB shares in huge size often below bid.For several weeks it remained impossible to sell anywhere near the market quote. If this scenario is repeated,the share price could retreat in a similar fashion to circa .12 pence.
25/1/2017
10:35
cpap man: No comment [as these are totally private matters] Dusseldorf....except to say that in life it is often what is NOT said that is so very interesting.... You sound a bit p*ssed off that you did not get a call but you can still currently buy FITB sub the placing price which many of us are obviously doing! Please keep your informative posts coming especially at this low point in terms of the FITB share price and ahead of what in my opinion could be a very bullish period of time! AIMHO / DYOR
18/1/2017
21:42
trt: The astonishing 500% rise in the share price of Fitbug Holdings PLC (LON:FITB) on Wednesday suggests the market is starting to believe.Before today's announcement of a huge contract win with a global financial services customer to provide "digital wellness" services to some 14,000 employees, the fitness tracking group might well have been thought of as a "me too" company.When one of those companies perceived to be a sector peer is electronics giant Apple, then a bit of doubt is understandable.Throw in a bit of confusion with the similarly named but much, much larger US company, the wearable health and fitness monitoring device maker Fitbit, and reticence to back the new management's focus on business-to-business (B2B) sales is even more understandable, even if the change of direction took it out of direct competition with Apple and Fitbit.Stretch-two-three-four, and pivot-two-three-fourAnna Gudmonson, who took over as chief executive officer in August 2015, said in June that management had "identified an attractive opportunity within the growing B2B corporate wellness market", but investors remained sceptical; the share price drifted lower in the second half of 2016."Corporate budgets for employee wellness are rising, and we have experienced demand for an integrated employee wellness solution," Gudmonson said back in June.It seems few believed her. Well, as the popular football chant (sung to the tune of "(S)he's a jolly good fellow") has it: "now you're gonna believe us, and now you're gonna believe us".Before today's announcement, Fitbug was already being used by global corporations to create a positive culture of health, maximise performance, reduce absenteeism and the risk of chronic illness among employees, and lower insurance premiums.Monitoring the signsInterim results covering the first half of 2016 showed a 52% increase in like-for-like sales in the B2B sector to £562,219, so clearly the new strategy was, as the sales people like to say, "gaining traction".True, the company also made a thumping half-year loss of £1.65mln, but this was about half the loss it suffered in the same period of 2015.Besides, making a loss for technology start-ups is the norm, even for one that helped pioneer the whole fitness-focused wearable technology scene back in 2015.So, perhaps we should have seen this coming.On the other hand, an order for 14,000 devices? That's big, for a company that yesterday was barely worth £2mln.Throw in the recuring revenue from additional services, and by the time of the full-year results for 2017, the company could find itself in rude health.Share John-H.jpgJohn Harrington
18/1/2017
12:51
mr hat: Fitbug shares more than double as it announces new customer win 10:10 18 Jan 2017 The fitness tracking group has inked a deal with a global financial services firm in Asia Business are starting to take the health of their employees more seriously Fitbug Holdings PLC’s (LON:FITB) move into the corporate wellness sector is continuing to pay dividends after the group announced a new customer win in Asia. The unnamed global financial services group – which has around 14,000 employees – will use Fitbug’s digital wellness services to help maximise workforce performance and productivity. London-based Fitbug has secured a one-year corporate wellness programme deal which includes ongoing service revenue as well as an order for 14,000 devices. The devices were shipped out last month and the programme is slated to start early this year. Fitbug is benefitting as businesses start to take the health of their employee’s more seriously in order to reduce absenteeism and risk of chronic illness, as well as to improve employee engagement. Shares in Fitbug went through the roof on Wednesday morning, up more than 110% at 9am to trade at 0.35p. Shares were up by almost 150%, or 0.24p, on Wednesday morning and were changing hands at 0.41p a pop. Not the easiest of rides Last year was a busy one for Fitbug as it looked to get its finances and operations back on track following a disappointing run during which losses continued to widen. The company changed tack and started to cut back on its “unsustainable” retail business and focus on opportunities within the corporate wellness sector last summer. Just before that, it had settled a long-running dispute with fellow health tech group Fitbit (NYSE:FIT) which had been costing hundreds of thousands of pounds in legal fees. Fitbug, which was established two years before Fitbit in 2005, argued that the similarity of the names created confusion and was damaging to its business and brand identity. The two settled out of court in a confidential agreement in February 2016. With a new strategy and freed from the legal issues that had clouded the business, Fitbug set about securing the finances to bring about a new dawn for the company. Its original founders, David Turner and Allan Fisher, agreed to convert an £8.4mln debt owed by the company to them into shares, while it also raised a further £2.6mln through another share issue. In its interims back in September, the company posted a loss of more than £1.6mln, although this was around half of the losses accrued in the same period a year earlier. -- Updates for background info and share price -- [...]
23/12/2015
16:32
liquid millionaire: FITB obviously have some serious supporters who truly believe in what they are doing. Todays RNS is better much better than endless dilutive share placings. I for one like it and can see why the FITB share price has responded the way that it has i.e. positive +
10/12/2014
13:40
liquid millionaire: FITB Repeat FITB Just out ref: FITB Subject: Fitbug Holdings PLC: £3.5m placing to fund sales drive Hybridan Research The provider of online personal health and wellbeing services yesterday announced a placing of £3.5m at a price of 9p. Fitbug has announced a string of high profile partnerships and retail agreements of late with the likes of Target and Samsung UK which sent the share price up to as high as 26.375p on an intraday basis. The funds will be predominantly applied to the marketing of the Fitbug Orb and the recently launched online coaching platform, Kiqplan, which is compatible with the majority of wearable devices. This combination, in our opinion, gives Fitbug a unique position to capitalise upon the fast growing demand for wearable technology, and incorporation of fitness tracking sensors into smartphones. We understand that the marketing strategy will be primarily focused on the US and UK. Fitbug will be attending the Consumer Electronics Show in January. Kiqplan has relevance to anybody wishing to achieve lifestyle improvement goals, and as such sponsorship of high profile public sporting events (fun runs etc) will provide a viable platform to reach new audiences. We also understand that Fitbug is pursuing a number of further retail partnerships and is seeking to appoint a global head of marketing. The admission of the placing shares on 30 December will be accompanied by the issue of 33.3m shares in respect of the conversion of 50% of a £1m loan note from Kifin Limited, a Kirsh Group subsidiary. Under the terms of the note issued in 2012 the conversion price is 1.5p. The company has for some time relied on the support of the Kirsh Group and NW1 Investments (a related party). The continuing support was demonstrated as recently as the 26 November announcement of the extension of all other loans to July 2016 (£6.9m). Within that figure is included loan proceeds of £2.35m issued in H2 2014. These funds combined with the placing proceeds, give Fitbug the resources to maximise its first mover advantage, and the opportunity to reach profitability with no further support from external backers. There are currently 13 million options of which 3 million are being surrendered and an additional 13.1 million are being granted including 8.5million to directors at the placing price under the enterprise management incentive scheme. David Turner, who currently holds 3m options intends to surrender these immediately after Admission following his move to a non-executive role earlier in 2014. CEO Malcolm Fried, having completed his task of refreshing Fitbug’s strategic direction, will be stepping down at the year end and Chairman, Fergus Kee, will revert to his executive role. Paul Landau, the founder of the Fitbug business, remains CEO of Fitbug Limited, the main operating company The combination of rapidly expanding retail base, and the high margin scalable cross-platform Kiqplans, give us confidence that H2 2014 and beyond will demonstrate rapid revenue growth. Should Target alone gross $100 per store per week in sales of Fitbug products that would add circa £3m in annual revenues. At this stage of Fitbug’s aggressive growth drive, revenue visibility is limited and we look forward to further details of due course. As we detailed in our note of 24 October, the wearable space has been the subject of much corporate activity with several transactions going through in excess of $100m. We believe that Fitbug’s capability of reaching multiple devices is unique in that it enables the company to target a higher proportion of the customers expected to buy over 43m of wearable bands worldwide next year. The recent launch of the Samsung Gear S and ever evolving pipeline of new devices, such as the Apple iWatch due for release in spring 2015 will keep the sector in focus for some time to come. The litigation against the market leader in basic bands, Fitbit, for trademark infringement is due to reach the courts in February 2015. We understand from the company that there is likely to be little downside and potentially significant upside for Fitbug from this case, and that under the US legal system costs cannot be awarded against a litigant who fails to prove their case. Fitbit on the other hand would appear to have much at risk including the potential loss of the Fitbit mark.
27/11/2014
09:15
waspfactory: Act your age not the FITB share price
25/11/2014
17:30
leebong: It’s been a fantastic few weeks for investors in Fitbug (LSE: FITB), with shares in the seller of fitness devices rising by a whopping 320% in the last week, and an incredible 5272% in the last month. The key reason for their very recent gains has been a deal struck with Samsung, with the electronics giant agreeing to include the company’s KiQplan digital coaching product on its Digital Health platform. The agreement could help to improve consumer awareness of Fitbug and, with the company offering additional features that are exclusively available to Samsung customers (such as a 12-week plan called ‘Fit+Healthy’), the move could help to build brand loyalty among Samsung customers. In addition, shares in Fitbug have also benefited in recent weeks from the stocking of the company’s products in Sainsbury’s, as well as in Target stores in the US. With such major retailers getting on board, the market clearly believes that Fitbug could have a bright future, and more major retailers could follow their peers and begin to stock the company’s products. Future Potential Clearly, wearable technology devices such as those sold by Fitbug have huge growth potential. Furthermore, when they are combined with a focus on health and wellbeing, it could prove to be a potent mix and, in this respect, Fitbug seems to have superb potential. In addition, a glance at Fitbug’s offering confirms that it could develop a niche product. That’s because it offers the same features as more expensive options, such as those sold by Nike, for a fraction of the cost. So, Fitbug could carve out its own segment in a fast-growing industry and make health-focused wearable technology devices much more accessible for consumers. This could be hugely beneficial to investors through a higher share price. Looking Ahead Of course, Fitbug remains a company that has no revenue and is therefore impossible to value. Furthermore, the chances of the company’s share price continuing its rise at the same pace are slim. After all, it has struck multiple deals with major corporations and, while others may follow, they are unlikely to cause such a dramatic rise in the company’s share price in the short run. That’s because further success appears to now be priced in, with the market seemingly anticipating sales figures to impress over the near term. Although wearable technology focused on health and wellbeing is undoubtedly an industry with vast potential, whether Fitbug can tap into that growth is yet to be tested. As a result, Fitbug remains a very high-risk play, with its share price set to remain volatile until data regarding its sales comes through. As such, prudent investors may wish to wait for evidence of its success – especially after a period of such strong share price growth – before buying a slice of the company. After all, patience has never lost anyone any money. Clearly, investing in Fitbug has been a highly profitable move for most investors in the stock
Fitbug share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20171018 20:31:21